FDA Approves Aimovig (erenumab-aooe) as a Preventive Treatment for Migraine

May 17, 2018 -- The U.S. Food and Drug Administration today approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections. Aimovig is the first FDA-approved preventive...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news

Related Links:

ConclusionsThough the available literature is mostly short-term, there is evidence that lithium monotherapy is reasonably safe and effective in children and adolescents, specifically for acute mania and for prevention of mood episodes.
Source: European Psychiatry - Category: Psychiatry Source Type: research
Publication date: Available online 18 August 2018Source: Meta GeneAuthor(s): Samar Amin, Tareq A. Wani, Zahoor Ahmad Kaloo, Seema Singh, Riffat John, Umer Majeed, Gowhar Ahmad ShapooAbstractInula royleana (Asteraceae) is a perennial medicinal herb native to Western Himalaya. In Kashmir Himalaya it is commonly known as ‘GugiPhool’. The plant has been traditionally used for various putative health benefits like headache, intestinal problems and blood pressure. The plant is rich source of alkaloids and other metabolites. The important medicinal properties which include antimicrobial, anti-inflammatory, antiprolife...
Source: Meta Gene - Category: Genetics & Stem Cells Source Type: research
Authors: Xu Y, Yu S, Zhang L, Zheng J, Chen Y, Che Y Abstract Application value of iterative reconstruction with computed tomographic angiography (CTA) in the patients with intractable headache was investigated. One hundred and eighty patients with headache, who were admitted and treated in Cangzhou Central Hospital, were selected to undergo CTA scan. The patients were divided into group A, B and C according to different scanning conditions and data reconstruction techniques. In group A, the scanning parameters were 120 kV and 300 mA, and filtered back projection (FBP) algorithm was used for data reconstruction. In...
Source: Experimental and Therapeutic Medicine - Category: General Medicine Tags: Exp Ther Med Source Type: research
We report the case of a 16-year-old Caucasian girl, who complained of headache, dizziness and paresis of the left side of her body. After physical examination and ancillary tests, she was diagnosed with Behçet's disease with neurological manifestations (neuro-Behçet's disease). She had a good response to treatment. IgG, IgA, IgM and albumin were quantified in serum and cerebrospinal fluid by single radial immunodiffusion. Intrathecal synthesis was found for the three classes of immunoglobulins. This is the first case in which the Reibergram was used to evaluate the neuroimmunological response in a patient wit...
Source: Reumatologia Clinica - Category: Rheumatology Source Type: research
Publication date: Available online 17 August 2018Source: British Journal of Oral and Maxillofacial SurgeryAuthor(s): L.F.O. Maciel, F.S. Landim, B.C. VasconcelosAbstractIn a prospective, observational study between April and November 2017 we evaluated the correlation between temporomandibular disorder (TMD), and otological signs and other symptoms in a sample of 251 patients. First, a simplified anamnestic questionnaire was applied for the diagnosis of TMD and the following symptoms were recorded: otalgia, tinnitus, vertigo, pruritus of the ear, feeling of hearing loss, fullness in the ear, headache, pain in the eye, neck ...
Source: British Journal of Oral and Maxillofacial Surgery - Category: ENT & OMF Source Type: research
PMID: 30113936 [PubMed - in process]
Source: Clinical Orthopaedics and Related Research - Category: Orthopaedics Authors: Tags: Clin Orthop Relat Res Source Type: research
Conclusions: Eye pain may be associated with a number of different causes, some benign and others sight- or life-threatening. Because patients with eye pain may present to either a neurology or an ophthalmology clinic and because the causes of eye pain may be primarily ophthalmic or neurologic, the diagnosis and management of these patients often requires collaboration and consultation between the 2 specialties.
Source: Journal of Neuro-Ophthalmology - Category: Opthalmology Tags: Original Contribution Source Type: research
The FDA today said it granted de novo approval for Brainsway‘s deep transcranial magnetic stimulation system, now indicated for treating obsessive compulsive disorder. The TMS system uses magnetic fields to simulate nerves in the brain, and has been shown to reduce the severity of OCD in patients. A 100-patient randomized, multi-center study of the device indicated that patients who received TMS treatment alongside medical management had a higher response rate, at 38%, than those treated with medical management and a sham device, at 11%. The most frequent adverse reaction was headache, which was reported by 37.5% of ...
Source: Mass Device - Category: Medical Devices Authors: Tags: Neurological Neuromodulation/Neurostimulation Regulatory/Compliance Brainsway Source Type: news
Conditions:   Pain, Postoperative;   Post-Craniotomy Headache Interventions:   Drug: Methylprednisolone;   Drug: Ropivacaine Sponsor:   Beijing Tiantan Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
BACKGROUND: To identify aggression and its association with suicidality in migraine patients. METHODS: We enrolled 144 migraine patients who made their first visit to our headache clinic. We collected data regarding their clinical characteristics a...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news
More News: Drugs & Pharmacology | Food and Drug Administration (FDA) | Headache | Migraine